Mobia Medical, Inc.

Mobia Medical, Inc. (MOBI) priced its initial public offering on May 8, 2026 at $15.00 per share, within its $14.00–$16.00 range, raising $150M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $496.3M. BofA Securities was lead-left underwriter, joined by J.P. Morgan, Goldman Sachs and BTIG and others. Latham & Watkins advised the company and Cleary Gottlieb advised the underwriters.

Mobia Medical, Inc. is a commercial-stage medical device company focused on stroke recovery. Its Vivistim Paired Vagus Nerve Stimulation System is FDA-approved for chronic ischemic stroke survivors with moderate to severe upper extremity impairments.

Status

IPO

Ticker

MOBI

Exchange

Nasdaq Global Select

Priced

May 8, 2026

IPO price

$15.00

Price range

$14.00–$16.00

Raised

$150M

Market cap at IPO price

$496.3M

First filed

Apr 17, 2026

Underwriters

BofA Securities, J.P. Morgan, Goldman Sachs, BTIG, Wolfe Research and Nomura

Company counsel

Latham & Watkins

Underwriters' counsel

Cleary Gottlieb

Sector

Healthcare

Country / state

TX

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.